Technical Analysis for PRQR - ProQR Therapeutics B.V.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 20 DMA | Bullish | -1.23% | |
| NR7 | Range Contraction | -1.23% | |
| Narrow Range Bar | Range Contraction | -1.23% | |
| 20 DMA Resistance | Bearish | 0.69% | |
| Down 3 Days in a Row | Weakness | 0.69% | |
| Down 4 Days in a Row | Weakness | 0.69% | |
| Down 5 Days in a Row | Weakness | 0.69% | |
| Fell Below 20 DMA | Bearish | -0.68% | |
| 1,2,3 Pullback Bullish | Bullish Swing Setup | -0.68% | |
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | -0.68% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | about 1 hour ago |
| 20 DMA Resistance | about 1 hour ago |
| Down 1% | about 1 hour ago |
| Fell Below 20 DMA | about 1 hour ago |
| 20 DMA Resistance | 2 days ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 08/01/2024
ProQR Therapeutics B.V., a biopharmaceutical company, is engaged in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. Its lead product candidate includes QR-010, a RNA-based oligonucleotide for the treatment of cystic fibrosis. The company was founded in 2012 and is headquartered in Leiden, the Netherlands.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cystic Fibrosis Oligonucleotide Regulus Therapeutics Alnylam Pharmaceuticals Therapeutic Gene Modulation Genetic Disorder Treatment Of Cystic Fibrosis
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cystic Fibrosis Oligonucleotide Regulus Therapeutics Alnylam Pharmaceuticals Therapeutic Gene Modulation Genetic Disorder Treatment Of Cystic Fibrosis
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 4.62 |
| 52 Week Low | 1.185 |
| Average Volume | 1,720,859 |
| 200-Day Moving Average | 2.19 |
| 50-Day Moving Average | 2.82 |
| 20-Day Moving Average | 3.67 |
| 10-Day Moving Average | 3.79 |
| Average True Range | 0.29 |
| RSI (14) | 56.33 |
| ADX | 38.52 |
| +DI | 23.18 |
| -DI | 14.47 |
| Chandelier Exit (Long, 3 ATRs) | 3.34 |
| Chandelier Exit (Short, 3 ATRs) | 4.03 |
| Upper Bollinger Bands | 4.04 |
| Lower Bollinger Band | 3.29 |
| Percent B (%b) | 0.5 |
| BandWidth | 20.46 |
| MACD Line | 0.23 |
| MACD Signal Line | 0.31 |
| MACD Histogram | -0.0725 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.85 | ||||
| Resistance 3 (R3) | 3.83 | 3.76 | 3.82 | ||
| Resistance 2 (R2) | 3.76 | 3.72 | 3.77 | 3.81 | |
| Resistance 1 (R1) | 3.72 | 3.69 | 3.74 | 3.73 | 3.80 |
| Pivot Point | 3.64 | 3.64 | 3.66 | 3.65 | 3.64 |
| Support 1 (S1) | 3.60 | 3.60 | 3.62 | 3.61 | 3.54 |
| Support 2 (S2) | 3.53 | 3.57 | 3.53 | 3.53 | |
| Support 3 (S3) | 3.48 | 3.53 | 3.52 | ||
| Support 4 (S4) | 3.49 |
